Showing results (2281-2290 of 2,940) with videos related to
Sort By:
Pageof 294
Cancer Investigation|May 8, 2015
Overexpression of miR-145-5p inhibits proliferation of prostate cancer cells and reduces SOX2 expressionMustafa Ozen, Omer Faruk Karatas, Sukru Gulluoglu, et al.Cancer Investigation|April 21, 2020
The Prognostic Significance of IGF-1R and the Predictive Risk Value of Circulating IGF-1 in Tunisian Patients with Laryngeal CarcinomaMariem Ben Elhadj, Aida Goucha, Asma Fourati, et al.Cancer Investigation|April 9, 2020
Construction of a Nomogram After Using Propensity Score Matching to Reveal the Prognostic Benefit of Tumor Resection of Stage IV M1a Nonsmall Cell Lung Cancer PatientsGuofang Yin, Hua Xiao, Yi Liao, et al.Cancer Investigation|May 20, 2021
Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World ExperienceAykut Bahçeci, Semra Paydaş, Naziye Ak, et al.Cancer Investigation|August 19, 2021
Risk of SARS-CoV2-Related Mortality in Non-Small Cell Lung Cancer Patients Treated with First-Line Immunotherapy Alone or in Combination with ChemotherapyGiuseppe Luigi Banna, Ornella Cantale, Alex Friedlaender, et al.Cancer Investigation|January 1, 1987
Isolation and characterization of an undifferentiated human colon carcinoma cell line (MIP-101)R M Niles, S A Wilhelm, G D Steele, et al.Cancer Investigation|December 3, 2004
How should we manage patients with "platinum-sensitive" recurrent ovarian cancer?Jonathan A Ledermann, Sarah WheelerCancer Investigation|December 3, 2004
Update on Gynecologic Oncology Group (GOG) trials in ovarian cancerRobert F OzolsCancer Investigation|December 3, 2004
First-line therapy for ovarian carcinoma: what's next?Tate ThigpenCancer Investigation|November 30, 2004
Determination of HER-2/neu overexpression and clinical predictors of survival in a cohort of 347 patients with primary malignant brain tumorsAnil Potti, Scott E Forseen, Vijay K Koka, et al.Pageof 294